While the use of each of these cytokines shows various benefits, the secretion of these cytokines will affect the patients in ways that are difficult to test in preclinical models, specifically in the likelihood of developing CRS due to an over-secretion of cytokines such as IL-6 (30). This evidence concerns the gene IL6 and congenital rubella syndrome.